SRTS Form 4 shows director increasing stake to 133,113 shares

Rhea-AI Filing Summary

Sensus Healthcare, Inc. (SRTS) reported an insider share purchase by a director. On 11/13/2025, the reporting person bought 2,500 shares of common stock in an open market transaction coded "P" at a price of $4.50 per share. After this transaction, the director beneficially owns 133,113 shares of Sensus Healthcare common stock, held directly. This filing reflects a change in insider ownership rather than an operating or financial update for the company.

Insider Trade Summary

Net Buyer: 2,500 shares ($11,250)

Net Buy 1 txn

Insider Sachetta Eric

Role Director

Bought 2,500 shs ($11K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	2,500	$4.50	$11K

Holdings After Transaction: Common Stock — 133,113 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sachetta Eric

(Last) (First) (Middle)

10 COBBLESTONE LANE

(Street)

ANDOVER MA 01810

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sensus Healthcare, Inc. [ SRTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/13/2025		P		2,500	A	$4.5	133,113	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Eric Sachetta	11/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction was reported for Sensus Healthcare (SRTS)?

A director of Sensus Healthcare reported buying 2,500 shares of common stock in a transaction dated 11/13/2025.

At what price were the SRTS shares purchased in this Form 4?

The 2,500 SRTS shares were purchased at a price of $4.50 per share in an open market transaction coded "P."

How many Sensus Healthcare shares does the insider own after this transaction?

Following the reported trade, the director beneficially owns 133,113 shares of Sensus Healthcare common stock, held directly.

What is the relationship of the reporting person to Sensus Healthcare (SRTS)?

The reporting person is identified as a Director of Sensus Healthcare, Inc. on the Form 4.

Does this SRTS Form 4 involve derivative securities like options or warrants?

No. The provided Form 4 excerpt shows activity only in common stock, with no derivative securities reported in Table II.

Is this Sensus Healthcare (SRTS) Form 4 filed for one or multiple reporting persons?

The form is indicated as filed by one reporting person, as shown in the Individual or Joint/Group Filing section.